Structure and function of the class C tetracycline/H+ antiporter: three independent groups of phenotypes are conferred by TetA (C).
The class C tetracycline/H+ antiporter, TetA(C), confers nine distinct phenotypes in Escherichia coli: resistance to tetracycline, reduced culture density at stationary phase (growth yield), increased supercoiling of plasmid DNA, delayed growth in succinate minimal medium, complementation of potassium uptake defects, increased susceptibility to cadmium, increased susceptibility to fusaric acid, increased susceptibility to bleomycin and increased susceptibility to several classes of cationic aminoglycoside antibiotics. These nine phenotypes were resolved into three 'linkage' groups based on their patterns of suppression by mutations of the tetA(C) gene of plasmid pBR322. Group I includes resistance to tetracycline, increased susceptibility to cadmium and reduced growth yield. Group II includes delayed growth in succinate minimal medium and complementation of potassium uptake defects. Group III includes increased supercoiling of plasmid DNA and increased susceptibilities to fusaric acid, bleomycin and cationic aminoglycosides. Phenotypes of Groups II and III, but not Group I, also were conferred by a chimeric gene encoding a fusion between the N-terminal 34 residues of TetA(C) and the C-terminal 429 residues of a structurally-similar protein, the E. coli galactose/H+ symporter, GalP. In contrast, none of these phenotypes was conferred by a chimeric gene encoding a fusion between the N-terminal 34 residues of TetA(C) and a structurally-dissimilar protein, TEM beta-lactamase. These results demonstrate that the three groups of linked phenotypes are dependent on different elements of the TetA(C) amino acid sequence, implying that TetA(C) confers these phenotypes by at least three independent mechanisms.
Griffith
J K
JK
Department of Cell Biology, University of New Mexico School of Medicine, Albuquerque 87131.
Cuellar
D H
DH
Fordyce
C A
CA
Hutchings
K G
KG
Mondragon
A A
AA
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D017920:Antiporters / Q000737:chemistry / Q000235:genetics* / Q000502:physiology*; D001426:Bacterial Proteins / Q000737:chemistry / Q000235:genetics* / Q000502:physiology*; D002874:Chromosome Mapping; D004252:DNA Mutational Analysis; D004278:DNA, Superhelical / Q000378:metabolism; D004357:Drug Synergism; D016368:Frameshift Mutation; D010641:Phenotype; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D013753:Tetracycline Resistance / Q000235:genetics
D000900:Anti-Bacterial Agents; D017920:Antiporters; D001426:Bacterial Proteins; D004278:DNA, Superhelical; C079051:tetA protein, Bacteria